Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission

OBJECTIVE: Patients with rheumatoid arthritis (RA) in whom remission is achieved following combination therapy with methotrexate plus etanercept face an ongoing medication burden. This study was undertaken to investigate whether sustained remission achieved on combination therapy can be maintained w...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Emery, Paul, Karis, Elaine, Haraoui, Boulos, Bykerk, Vivian, Yen, Priscilla K., Kricorian, Greg, Chung, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251940/
https://www.ncbi.nlm.nih.gov/pubmed/33205906
http://dx.doi.org/10.1002/art.41589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251940/
https://www.ncbi.nlm.nih.gov/pubmed/33205906
http://dx.doi.org/10.1002/art.41589

Ejemplares similares